Keyphrases
Anastrozole
28%
Androgen Priming
42%
Antagonist Protocol
42%
Anti-Mllerian Hormone
42%
Antral Follicle Count
27%
Aromatase Inhibitors
42%
Basal FSH
21%
Controlled Ovarian Stimulation
42%
Early Follicular Phase
42%
Excessive Response
16%
Fertile Age
42%
Follicular Depletion
42%
Goserelin
28%
High-quality Embryo
21%
Hormone Concentration
42%
In Vitro Fertilization
42%
Intrauterine Insemination
42%
IVF Patients
42%
IVF-ICSI
21%
Mature Follicles
40%
Mild Stimulation
42%
Nomogram
42%
Ovarian Response
60%
Ovarian Volume
19%
Ovulatory
42%
Patient Risk
16%
Recombinant FSH
42%
Recombinant Human Follicle-stimulating Hormone (r-hFSH)
60%
Singleton
42%
Small-for-gestational Age
42%
Spontaneous Reduction
42%
Standard Patient
42%
Vanishing Twin
85%
Medicine and Dentistry
Anastrozole
17%
Androgen
42%
Antral Follicle
75%
Aromatase Inhibitor
85%
Clinician
16%
Downregulation
42%
Follicle
33%
Follicular Phase
42%
Follitropin
74%
Gonadotropin-Releasing Hormone
85%
Goserelin
17%
Hormone Determination
42%
Inhibin B
25%
Intracytoplasmic Sperm Injection
85%
Menstrual Cycle
16%
Recombinant
34%
Twin Pregnancy
21%
Pharmacology, Toxicology and Pharmaceutical Science
Anastrozole
28%
Androgen
42%
Aromatase Inhibitor
85%
Endometrium Tumor
42%
Follitropin
100%
Goserelin
28%
Hormone Cancer Therapy
21%
Prospective Study
21%
Recombinant Follitropin
85%
Twin Pregnancy
42%
